Evaluating Ovarian Toxicity Outcomes Following Immunotherapy in Patients With Triple-Negative Breast Cancer (TNBC)
Clinical trial NCT07527819 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07527819
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-08
- Primary completion
- 2031-04-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.